Article Details

AstraZeneca Acquires Amolyt Pharma for $1.05 Billion in Rare Diseases Expansion Deal

Retrieved on: 2024-03-15 19:46:48

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Acquires Amolyt Pharma for $1.05 Billion in Rare Diseases Expansion Deal. View article details on HISWAI: https://www.breakinglatest.news/business/astrazeneca-acquires-amolyt-pharma-for-1-05-billion-in-rare-diseases-expansion-deal/

Excerpt

AstraZeneca's move to strengthen its rare diseases portfolio comes after its successful acquisition of Alexion in 2021, which saw revenue from rare ...

Article found on: www.breakinglatest.news

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up